Malvern, PA, United States of America

Niels Peter Ryde

USPTO Granted Patents = 20 


 

Average Co-Inventor Count = 3.3

ph-index = 8

Forward Citations = 449(Granted Patents)


Company Filing History:


Years Active: 2002-2023

Loading Chart...
Loading Chart...
Loading Chart...
20 patents (USPTO):Explore Patents

Title: Niels Peter Ryde: An Innovator in Nanoparticulate Compositions

Introduction

Niels Peter Ryde, based in Malvern, PA, is a notable inventor recognized for his contributions to the field of nanoparticulate compositions. With an impressive portfolio of 20 patents, Ryde continues to influence advancements in pharmaceutical formulations and drug delivery systems. His innovative approaches are paving the way for more effective utilization of active agents in various applications.

Latest Patents

One of Ryde's most significant recent inventions focuses on the reduction of flake-like aggregation in nanoparticulate active agent compositions. This innovative patent addresses challenges associated with nanoparticulate compositions by introducing methods to minimize aggregation. The invention encompasses compositions comprising a nanoparticulate active agent combined with at least one surface stabilizer and a flake-like aggregation reducing agent, such as a buffer and a sugar. The active agent compositions are characterized by particles with an effective average particle size of less than about 2000 nm, enhancing their efficacy in pharmaceutical applications.

Career Highlights

Throughout his career, Niels Peter Ryde has made substantial contributions while working with prominent companies in the pharmaceutical industry, including Elan Pharma International Limited and Alkermes Pharma Ireland Limited. His experience in these organizations has afforded him the opportunity to develop innovative solutions that push the boundaries of current technology in drug delivery systems.

Collaborations

Ryde has collaborated with talented professionals, including Stephen B. Ruddy and Peter Snyder. These collaborations have enabled the exchange of ideas and research findings, fostering an environment conducive to innovation and discovery in nanoparticulate formulations.

Conclusion

Niels Peter Ryde stands out in the field of nanoparticulate active agent compositions with his wealth of experience and groundbreaking inventions. His recent patents reflect a dedication to improving pharmaceutical formulations, ultimately enhancing therapeutic efficacy. As he continues to innovate, he remains a significant figure in advancing drug delivery technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…